NCT00126516View on ClinicalTrials.gov

Angiotensin II Receptor Blockers (ARB) and ACE Inhibitors (ACEI) on Silent Brain Infarction and Cognitive Decline

PHASE4CompletedINTERVENTIONAL
Enrollment

395

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Brain InfarctionHypertension
Interventions
DRUG

Angiotensin II Receptor Antagonists

any dosage, frequency, and duration

DRUG

Angiotensin-converting Enzyme Inhibitors

any dosage, frequency, and duration

Trial Locations (1)

634-8522

First Department of Internal Medicine, Nara Medical University, Kashihara

Sponsors
All Listed Sponsors
lead

Nara Medical University

OTHER

NCT00126516 - Angiotensin II Receptor Blockers (ARB) and ACE Inhibitors (ACEI) on Silent Brain Infarction and Cognitive Decline | Biotech Hunter | Biotech Hunter